Showing results (921-930 of 3,789) with videos related to

Sort By:
Pageof 379
Oncoimmunology|January 18, 2021
Anti-PD-1 antibody HX008 combined with oxaliplatin plus capecitabine for advanced gastric or esophagogastric junction cancer: a multicenter, single-arm, open-label, phase Ib trialJianming Xu, Nong Xu, Yuxian Bai, et al.
Oncoimmunology|January 18, 2021
Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccinationWouter W van Willigen, Martine Bloemendal, Marye J Boers-Sonderen, et al.
Oncoimmunology|January 18, 2021
Cancer immunotherapy based on blocking immune suppression mediated by an immune modulator LAIR-1Lijun Xu, Shanlong Wang, Jufeng Li, et al.
Oncoimmunology|January 18, 2021
Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigenZoila A Lopez-Bujanda, Matthew G Chaimowitz, Todd D Armstrong, et al.
Oncoimmunology|January 18, 2021
Identification of novel autoantibodies based on the protein chip encoded by cancer-driving genes in detection of esophageal squamous cell carcinomaGuiying Sun, Hua Ye, Xiao Wang, et al.
Oncoimmunology|January 18, 2021
Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor responseHiroaki Mashima, Rong Zhang, Tsuyoshi Kobayashi, et al.
Oncoimmunology|January 18, 2021
Reviving the role of MET in liver cancer therapy and vaccination: an autophagic perspectiveXing Huang, Gang Zhang, Xueli Bai, et al.
Oncoimmunology|January 18, 2021
Improving the anti-solid tumor efficacy of CAR-T cells by inhibiting adenosine signaling pathwayNa Li, Na Tang, Chen Cheng, et al.
Oncoimmunology|January 18, 2021
Adapter chimeric antigen receptor (AdCAR)-engineered NK-92 cells: an off-the-shelf cellular therapeutic for universal tumor targetingStefan Grote, Joerg Mittelstaet, Caroline Baden, et al.
Oncoimmunology|February 4, 2021
T cells expanded from renal cell carcinoma display tumor-specific CD137 expression but lack significant IFN-γ, TNF-α or IL-2 productionSaskia D van Asten, Rosa de Groot, Marleen M van Loenen, et al.
Pageof 379